Patent · US Active

TRPV4 antagonists

US11260049B2 · kind B2 · utility

0Cited by

1References

28Claims

0Family size

Assignee

GlaxoSmithKline Intellectual Property (No. 4) Limited · GB

Inventors

Edward J. Brnardic · Lansdale, US
Carl Brooks · King of Prussia, US
Brian Griffin Lawhorn · King of Prussia, US
Peng Li · New York, US
Jay M. Matthews · Lansdale, US
John Jeffrey McAtee · Collegeville, US
Joseph E. Pero · Harleysville, US
Matthew Robert Sender · Collegeville, US
Lamont Roscoe Terrell · Collegeville, US
David J. Behm · Collegeville, US

Key dates

Filing date	Sep 20, 2017
Grant date	Mar 1, 2022
Priority date	—
Expiry date	Oct 23, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D498/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to pyrrolidine sulfonamide analogs, pharmaceutical compositions containing them and their use as TRPV4 antagonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.